57
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
785053
Humanized Disease Models - Boosting 3D Drug Development Models to the ex vivo Level
- Arne-Christian Faisst: CEO, Co-Founder, Owner, and PresidentPast Role: 4D Lifetec, Owner, Co-Founder, Chairman, and Delegated CEO
About the Company
abc biopply is a CRO with its own specifically designed proprietary 3D cell culture platform 3D CoSeedis™.
abc biopply’s proprietary technology creates hundreds of miniature versions of patient organs in a laboratory setting, using both healthy and diseased tissues. Their innovative models bridge the gap in predictability between the lab and the
clinic.
The company offers a comprehensive portfolio of validated service packages based on the proprietary 3D CoSeedis in chip communication technology™. Utilizing 3D CoSeedis humanized multi-organoid models™, as well as traditional monolayer models, they specialize in assay endpoints useful for drug discovery and pharmaceutical development.
